FDA panel endorses Johnson & Johnson's COVID-19 vaccine

A U.S. Food and Drug Administration advisory panel on Friday voted to endorse Johnson & Johnson’s coronavirus vaccine, clearing the way for FDA leaders to grant emergency use authorization amid the ongoing fight against COVID-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.